Ordinary-course related-party trade transactions

Hong Kong IPO disclosure precedents · 138 companies, 139 items

General related-party/connected transactions entered into in the track record, disclosed per the accountant's report, which are trade in nature and conducted on arm's-length or normal commercial terms.

2026-06-30Prospectus
Luxshare Precision Industry Co., Ltd.立讯精密工业股份有限公司02475.HK

During the Track Record Period, our transactions with related parties mainly consisted of (i) sales of goods; (ii) purchases of goods; (iii) leased out buildings to related parties, (iv) leased buildings from related parties; (v) provision of labor services and (vi) purchase of labor services.

Financial Information · p. 247

It is the view of our Directors that each of the related party transactions set out in Note 44 of the Accountants’ Report in Appendix I to this prospectus (i) was conducted on normal commercial terms and/or on terms not less favorable than terms available from Independent Third Parties, which are considered fair, reasonable and in the interest of our Shareholders as a whole; and (ii) does not distort our Track Record Period results or make our historical results not reflective of future performance.

Financial Information · p. 247

We have applied for, and the Stock Exchange has granted us, a waiver from strict compliance with certain requirements set out in Chapter 14A of the Listing Rules for certain continuing connected transactions.

Summary · p. 3
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-30Application Proof
Autel Intelligent Technology Corp., Ltd.深圳市道通科技股份有限公司

Related party transactions are set out in Note 40 to the Accountants’ Report included in Appendix I, Our Directors confirm that these transactions were conducted in the ordinary and usual course of business and on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.

Financial Information · p. 188
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-30Prospectus
Guangdong Dtech Technology Co., Ltd.广东鼎泰高科技术股份有限公司01377.HK

During the Track Record Period, save for Channel Partner A (the ''Relevant Channel Partner''), in which we held an approximately 3% equity interest, all of our channel partners were Independent Third Parties.

Business · p. 150

Our equity interest in the Relevant Channel Partner was a minority, passive investment and did not confer control or significant influence over the Relevant Channel Partner.

Business · p. 150

We held such minority interest in, and conducted business with, the Relevant Channel Partner primarily because, to the best of our Directors' knowledge after making reasonable enquiries, the Relevant Channel Partner possessed downstream customer resources that were complementary to our business and could facilitate the development of our customer base.

Business · p. 150
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-29Prospectus
EACON Group Co., Ltd易控智驾科技股份有限公司07687.HK

In 2024 and 2025, we entered into related party transactions of RMB65.2 million and RMB42.1 million, primarily relating to sales of autonomous mining trucks.

Financial Information · p. 239

The amount due from related parties of RMB9.9 million as of December 31, 2025 is non-trade in nature and is expected to be collected upon the Listing.

Financial Information · p. 233

Our Directors are of the view that each of the related party transactions was conducted in the ordinary course of business on an arm’s-length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 238
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-26Application Proof
Shenzhen Megmeet Electrical Co., Ltd.深圳麦格米特电气股份有限公司

During the Track Record Period, we primarily conducted related party transactions with our associates, investee companies and entities controlled by our ultimate controlling party.

Financial Information · p. 226

Our Directors believe that our transactions set out in Note 36 to the Accountants’ Report in Appendix I during the Track Record were conducted in the normal course of business and on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.

Financial Information · p. 226
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-26Application Proof
Shanghai Union Technology Corporation上海联泰科技股份有限公司

We enter into transactions with our related parties from time to time.

Financial Information · p. 209

Our Directors are of the view that each of the related party transactions set forth in Note 34 of the Appendix I to this Document was conducted in the ordinary course of business and with normal commercial terms on an arm’s length basis between the relevant parties.

Financial Information · p. 209

Our Directors are also of the view that our related party transactions during the Track Record Period would not distort our track record results or cause our historical results to become non-reflective of our future performance.

Financial Information · p. 209
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-22Application Proof
Taihe Music Group太合音乐集团

We enter into transactions with our related parties from time to time.

Financial Information · p. 220

Our Directors are of the view that each of the related party transactions set out in Note 34 to the Accountant’s Report included in Appendix I to this document was conducted in the ordinary course of business on an arm’s length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 220

Our Directors are also of the view that our related party transactions during the Track Record Period would not distort our track record results or cause our historical results to become non-reflective of our future performance.

Financial Information · p. 220
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-22Prospectus
Guangdong True Health Medical Technology Development Co., Ltd.广东真健康医疗科技开发股份有限公司02697.HK

During the Track Record Period, our transactions with related parties mainly included provision of certain research and development services to our associate company, guarantee provided by Ms. Cheong in respect of certain loan facility, guarantee provided by our Company in respect of repurchase obligation of Ms. Cheong pursuant to the shareholders’ agreement under Series B Financing, which had been terminated and considered void ab initio, and compensation paid to our key management personnel.

Financial Information · p. 255

It is the view of our Directors that each of the related party transactions set out in note 32 of the Accountants’ Report in Appendix I to this prospectus (i) were conducted on normal commercial terms and/or on terms not less favorable than terms available from Independent Third Parties, which are considered fair, reasonable and in the interest of our Shareholders as a whole; and (ii) do not distort our Track Record Period results or make our historical results not reflective of future performance.

Financial Information · p. 255

Our prepayments, deposits and other receivables as recognized under current assets increased from RMB8.1 million as of December 31, 2024 to RMB11.7 million as of December 31, 2025, primarily due to (i) an increase in deferred listing expenses of RMB3.7 million; (ii) prepayments for purchases of inventories; and (iii) the recognition of loans receivables from related parties of RMB1.0 million, reflecting the loans we provided to our associate for working capital purpose.

Financial Information · p. 248
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-18Application Proof
Guangzhou Zhiyi Biotechnology Co., Ltd.广州知易生物科技股份有限公司

During the Track Record Period, we entered into the material related party transaction comprising key management personnel remuneration.

Financial Information · p. 257

Remuneration for key management personnel of our Group, including amounts paid to our Directors and supervisors, amounted to RMB16.0 million and RMB17.1 million in 2024 and 2025, respectively, comprising salaries, allowances and other benefits, discretionary bonuses, retirement scheme contributions and equity-settled share-based payments.

Financial Information · p. 257

Our Directors are of the view that such related party transactions and balances did not distort our track record results or cause our historical results to become non-reflective of our future performance.

Financial Information · p. 257
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-17Prospectus
LINGYI iTECH (GUANGDONG) COMPANY广东领益智造股份有限公司01688.HK

During the Track Record Period, we have entered into a number of related party transactions, which primarily consisted of the purchase and sale of goods, provision and receipt of services, and leasing of properties with our associates and other related parties.

Financial Information · p. 264

During the Track Record Period, certain of our bank loans and issued bonds were guaranteed by related parties. All such guarantees had been fully released.

Financial Information · p. 265
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-16Application Proof

During the Track Record Period, we entered into certain transactions with our related parties.

Financial Information · p. 226

These transactions primarily include but are not limited to (i) compensation to our key personnel, (ii) guarantees provided by our subsidiaries with respect to certain banking facilities, (iii) sale of our products to our associates, (iv) purchase of goods from our associates, and (v) rental expenses paid to an associate.

Financial Information · p. 226

Our Directors confirm that our related party transactions did not cause any distortion of our results of operations or make our historical results not reflective in the Track Record Period.

Financial Information · p. 226
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-15Application Proof
TRIAPEX LABORATORIES CO., LTD.江苏鼎泰药物研究(集团)股份有限公司

In 2024 and 2025, we purchased site management services from one of our associates to facilitate our clinical study services, amounting to RMB1.0 million and RMB7.5 million, respectively.

Financial Information · p. 229

Our Directors believe that the transactions were conducted on normal commercial terms and on an arm's length basis in the ordinary and usual course of business and did not distort our results of operations or render our historical results not reflective of our future performance.

Financial Information · p. 229
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-11Application Proof
Audiowell Electronics (Guangdong) Co., Ltd.广东奥迪威传感科技股份有限公司

See Note 38 to the Accountants' Report set out in Appendix I to this Document for further details on our material related party transactions.

Financial Information · p. 228

Our Directors confirm that all transactions with related parties described in Note 38 of the Accountants' Report set out in Appendix I to this Document were conducted in the ordinary course of business on an arm's length basis and with on normal commercial terms and/or on terms not less favorable than terms available from independent third parties, which are considered fair, reasonable and in the interest of the Shareholders of our Company as a whole.

Financial Information · p. 228
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-08Application Proof
Hangzhou Highlightll Pharmaceutical Co., Ltd.杭州高光制药股份有限公司

During the Track Record Period, we entered into certain transactions with our related parties.

Financial Information · p. 245

Our Directors confirm that each of the significant related party transactions during the Track Record Period was conducted on an arm’s length basis, and would not distort our results of operations over the Track Record Period or make our historical results not reflective of our future performance.

Financial Information · p. 245
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-06-05Application Proof
Shenzhen CVA Innovation Co., Ltd.深圳曦华科技股份有限公司

Our related party transactions during the Track Record Period primarily included sales of goods to Nanning Qingzhi.

Financial Information · p. 222

Our Directors are of the view that our related party transactions during the Track Record Period were conducted in the ordinary course of business at arm’s length with reference to normal commercial terms, and would not distort our track record results or make our historical results not reflective of our future performance.

Financial Information · p. 222

Included in deposits and other receivables is an amount due from an associate of RMB1.9 million, RMB3.0 million and nil, which is net of impairment of RMB0.1 million, RMB0.2 million and RMB3.1 million as of December 31, 2023, 2024 and 2025, respectively, which bears an interest rate at 4% per annum.

Financial Information · p. 211
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-28Prospectus
Lung Fung Group Holdings Limited龙丰集团控股有限公司02290.HK

One of our Wholesale Customers during the Track Record Period was a company owned by the sister of Mr. Tse, which is a connected person of our Company (''Relevant Wholesale Customer'').

Business · p. 153

Sales to this Wholesale Customer were conducted on normal commercial terms and at prices comparable to other third-party customers, and amounted to HK$1.9 million, HK$6.7 million, HK$6.4 million and nil for FY2023, FY2024 and FY2025 and 8MFY2026, respectively.

Business · p. 153

Except for the Relevant Wholesale Customer, none of our Directors or any Shareholders who owns more than 5% of the share capital of our Company as at the Latest Practicable Date, nor any of their respective associates, had any interest, directly or indirectly, in any of our five largest customers or any of the Wholesale Customers for each year/period during the Track Record Period.

Business · p. 154
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-28Application Proof
SHANGHAI KEYING E-COMMERCE CO., LTD.上海凯诘电子商务股份有限公司

During the Track Record Period, we had entered into certain related party transactions, which mainly included purchase from related parties representing promotional services we procured.

Financial Information · p. 225

Our Directors confirm that all material related party transactions during the Track Record Period were conducted on an arm’s length basis, and would not distort our results of operations over the Track Record Period or make our historical results over the Track Record Period not reflective of our expectations for our future performance.

Financial Information · p. 225
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-27Application Proof
Aier Eye Hospital Group Co., Ltd.爱尔眼科医院集团股份有限公司

Our Directors are also of the view that all material related party transactions during the Track Record Period were conducted on normal commercial terms or on terms no less favorable to our Group than those available from independent third parties, are fair and reasonable and in the interests of our Shareholders as a whole, and would not distort our track record results or make our historical results not reflective of our expectations for our future performance.

Financial Information · p. 249

We will continue to engage in certain connected transactions after the [REDACTED].

Summary · p. 12

We have applied to the Stock Exchange for, and the Stock Exchange [has granted], a waiver to us under Rule 14A. 105 of the Listing Rules from strict compliance with the announcement, circular and independent Shareholders’ approval requirements.

Summary · p. 12
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-27Application Proof
Sino Medical Sciences Technology Inc.赛诺医疗科学技术股份有限公司

Our Directors are of the view that each of the related party transactions set out in Note 33 to the Accountants’ Report included in Appendix I to this document was conducted in the ordinary course of business on an arm’s length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 220

Our Directors are also of the view that our related party transactions during the Track Record Period would not distort our track record results or cause our historical results to become non-reflective of our future performance.

Financial Information · p. 220
The company's explanation, the adviser's view and the page in the filing: see Matters
2026-05-26Application Proof
Freetech (Zhejiang) Intelligent Technology Co., Ltd.福瑞泰克(浙江)智能科技股份有限公司

Substantially all of our balances with related parties were trade in nature during the Track Record Period. We expect that the balances with related parties that were non-trade in nature will be settled before the proposed [REDACTED].

Financial Information · p. 264

Our Directors are of the view that each of the related party transactions set out in Note 37 to the Accountant's Report included in Appendix I to this Document was conducted in the ordinary course of business on an arm's length basis and with normal commercial terms between the relevant parties.

Financial Information · p. 264
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us